1. Home
  2. RSF vs NEPH Comparison

RSF vs NEPH Comparison

Compare RSF & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RiverNorth Capital and Income Fund

RSF

RiverNorth Capital and Income Fund

HOLD

Current Price

$14.64

Market Cap

63.1M

Sector

Finance

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$4.42

Market Cap

60.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RSF
NEPH
Founded
2016
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.1M
60.0M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
RSF
NEPH
Price
$14.64
$4.42
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
11.8K
47.0K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
10.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$17,930,000.00
Revenue This Year
N/A
$33.32
Revenue Next Year
N/A
$12.27
P/E Ratio
N/A
$32.70
Revenue Growth
N/A
32.36
52 Week Low
$14.81
$1.39
52 Week High
$16.23
$6.42

Technical Indicators

Market Signals
Indicator
RSF
NEPH
Relative Strength Index (RSI) 63.59 41.01
Support Level $14.31 $4.74
Resistance Level $14.47 $5.46
Average True Range (ATR) 0.09 0.32
MACD 0.03 -0.04
Stochastic Oscillator 86.71 7.14

Price Performance

Historical Comparison
RSF
NEPH

About RSF RiverNorth Capital and Income Fund

RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: